Literature DB >> 23351992

Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update.

Kasiani C Myers1, Stella M Davies, Akiko Shimamura.   

Abstract

Shwachman-Diamond syndrome (SDS) is an inherited neutropenia syndrome associated with a significant risk of aplastic anemia and malignant transformation. Multiple additional organ systems, including the pancreas, liver, and skeletal and central nervous systems, are affected. Mutations in the Shwachman-Bodian-Diamond syndrome (SBDS) gene are present in most patients. There is growing evidence that SBDS functions in ribosomal biogenesis and other cellular processes. This article summarizes the clinical phenotype of SDS, diagnostic and treatment approaches, and novel advances in our understanding of the molecular pathophysiology of this disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23351992      PMCID: PMC5693339          DOI: 10.1016/j.hoc.2012.10.003

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  50 in total

1.  Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7.

Authors:  S Goobie; M Popovic; J Morrison; L Ellis; H Ginzberg; G R Boocock; N Ehtesham; C Bétard; C G Brewer; N M Roslin; T J Hudson; K Morgan; T M Fujiwara; P R Durie; J M Rommens
Journal:  Am J Hum Genet       Date:  2001-03-15       Impact factor: 11.025

2.  Enteropathic histopathological features may be associated with Shwachman-Diamond syndrome.

Authors:  N Shah; H Cambrook; J Koglmeier; C Mason; P Ancliff; K Lindley; V V Smith; M Bajaj-Elliott; N J Sebire
Journal:  J Clin Pathol       Date:  2010-05-24       Impact factor: 3.411

3.  Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; June A Peters; Jennifer T Loud; Lisa Leathwood; Ann G Carr; Mark H Greene; Philip S Rosenberg
Journal:  Br J Haematol       Date:  2010-04-30       Impact factor: 6.998

4.  Immune function in patients with Shwachman-Diamond syndrome.

Authors:  Y Dror; H Ginzberg; I Dalal; V Cherepanov; G Downey; P Durie; C M Roifman; M H Freedman
Journal:  Br J Haematol       Date:  2001-09       Impact factor: 6.998

5.  Shwachman-Diamond syndrome: An inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment.

Authors:  Y Dror; M H Freedman
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

6.  Psychological characteristics of children with Shwachman syndrome.

Authors:  A Kent; G H Murphy; P Milla
Journal:  Arch Dis Child       Date:  1990-12       Impact factor: 3.791

7.  Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.

Authors:  Jean Donadieu; Thierry Leblanc; Brigitte Bader Meunier; Mohamed Barkaoui; Odile Fenneteau; Yves Bertrand; Micheline Maier-Redelsperger; Marguerite Micheau; Jean Louis Stephan; Noel Phillipe; Pierre Bordigoni; Annie Babin-Boilletot; Philippe Bensaid; Anne Marie Manel; Etienne Vilmer; Isabelle Thuret; Stephane Blanche; Eliane Gluckman; Alain Fischer; Françoise Mechinaud; Bertrand Joly; Thierry Lamy; Olivier Hermine; Bruno Cassinat; Christine Bellanné-Chantelot; Christine Chomienne
Journal:  Haematologica       Date:  2005-01       Impact factor: 9.941

8.  The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.

Authors:  Philip S Rosenberg; Blanche P Alter; Audrey A Bolyard; Mary Ann Bonilla; Laurence A Boxer; Bonnie Cham; Carol Fier; Melvin Freedman; George Kannourakis; Sally Kinsey; Beate Schwinzer; Connie Zeidler; Karl Welte; David C Dale
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

9.  Shwachman's syndrome. A review of 21 cases.

Authors:  P J Aggett; N P Cavanagh; D J Matthew; J R Pincott; J Sutcliffe; J T Harries
Journal:  Arch Dis Child       Date:  1980-05       Impact factor: 3.791

10.  Steatorrhea and pancreatic insufficiency in Shwachman syndrome.

Authors:  R E Hill; P R Durie; K J Gaskin; G P Davidson; G G Forstner
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

View more
  41 in total

1.  Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.

Authors:  Daria V Babushok; Monica Bessler; Timothy S Olson
Journal:  Leuk Lymphoma       Date:  2015-12-23

2.  Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry.

Authors:  David C Dale; Audrey Anna Bolyard; Laurie A Steele; Cornelia Zeidler; Karl Welte
Journal:  Curr Opin Hematol       Date:  2020-01       Impact factor: 3.284

Review 3.  Genetic predisposition syndromes: when should they be considered in the work-up of MDS?

Authors:  Daria V Babushok; Monica Bessler
Journal:  Best Pract Res Clin Haematol       Date:  2014-11-12       Impact factor: 3.020

4.  Old and new faces of neutropenia in children.

Authors:  Carlo Dufour; Maurizio Miano; Francesca Fioredda
Journal:  Haematologica       Date:  2016-07       Impact factor: 9.941

5.  SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing.

Authors:  Christoph Schürch; Thorsten Schaefer; Joëlle S Müller; Pauline Hanns; Marlon Arnone; Alain Dumlin; Jonas Schärer; Irmgard Sinning; Klemens Wild; Julia Skokowa; Karl Welte; Raphael Carapito; Seiamak Bahram; Martina Konantz; Claudia Lengerke
Journal:  Blood       Date:  2021-03-11       Impact factor: 22.113

Review 6.  Inherited bone marrow failure syndromes: considerations pre- and posttransplant.

Authors:  Blanche P Alter
Journal:  Blood       Date:  2017-11-23       Impact factor: 22.113

Review 7.  Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives.

Authors:  Valentino Bezzerri; Marco Cipolli
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

8.  Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells.

Authors:  Melisa Ruiz-Gutierrez; Özge Vargel Bölükbaşı; Gabriela Alexe; Adriana G Kotini; Kaitlyn Ballotti; Cailin E Joyce; David W Russell; Kimberly Stegmaier; Kasiani Myers; Carl D Novina; Eirini P Papapetrou; Akiko Shimamura
Journal:  JCI Insight       Date:  2019-04-30

Review 9.  Old and new tools in the clinical diagnosis of inherited bone marrow failure syndromes.

Authors:  Allison H West; Jane E Churpek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

10.  Why is an energy metabolic defect the common outcome in BMFS?

Authors:  Paolo Degan; Silvia Ravera; Enrico Cappelli
Journal:  Cell Cycle       Date:  2016-08-11       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.